nimotuzumab

Related by string. Nimotuzumab * * products nimotuzumab humanized . Nimotuzumab anti . evaluating nimotuzumab *

Related by context. Frequent words. (Click for all words.) 65 perifosine 62 CYT# 62 satraplatin 61 FOLOTYN 59 Multikine 59 randomized Phase 58 picoplatin 58 carfilzomib 57 lapatinib 57 ABRAXANE 57 bavituximab 57 clinical trials 57 PROVENGE 57 Oncophage 57 brain metastases 57 dose escalation 57 Ceplene 57 Phase III clinical 56 BiovaxID 56 fidaxomicin 56 capecitabine 56 TYSABRI 56 pivotal Phase III 56 docetaxel 56 Dacogen 55 clinical trial 55 Prochymal 55 Phase III clinical trials 55 Vidaza 55 Phase IIb clinical 55 hematologic malignancies 55 RG# [001] 55 Vectibix 55 VELCADE 55 Genasense 54 ANA# 54 XL# [003] 54 pixantrone 54 ERBITUX 54 Phase III trials 54 REOLYSIN 54 pivotal Phase 54 Soliris 54 sorafenib 54 Phase IIb 54 bone metastases 54 NSCLC 54 preclinical studies 54 Abraxane 54 soft tissue sarcoma 53 sunitinib 53 metastatic colorectal cancer 53 Phase 1b 53 Phase 2b clinical 53 Locteron 53 REOLYSIN R 53 hormone refractory prostate cancer 53 investigational 53 hematological malignancies 53 Tovaxin 52 Phase IIb trial 52 pirfenidone 52 REVLIMID 52 cetuximab 52 Nexavar 52 Xeloda 52 preclinical 52 Actemra 52 MGCD# [002] 52 investigational drug 52 metastatic melanoma 52 solid tumors 52 gemcitabine 51 Tarceva 51 cytarabine 51 trastuzumab 51 paclitaxel 51 taxane 51 bortezomib 51 Zevalin 51 Phase IIa clinical 51 rituximab 51 ENMD 50 Phase 2b 50 oral mucositis 50 hepatocellular carcinoma 50 Campath 50 monotherapy 50 RDEA# 50 G CSF 50 clinical 50 tolerability 50 bevacizumab 50 AzaSite 50 Erbitux 50 cytotoxic 50 Phase III 50 carboplatin 50 XIAFLEX 49 immunogenicity 49 therapeutic antibody

Back to home page